Short communicationp-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities

Add time:09/06/2019    Source:sciencedirect.com

C. Díaz, J. M. Gutiérrez, B. Lomonte and J. Núñez. p-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities. Toxicon31, 1202–1206, 1993.—Modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2 variant, was carried out with p-bromophenacyl bromide. Modified toxin did not show changes in its charge and immunological properties but two of its pharmacological activities were modified. Myotoxic activity, measured by histology and by increment of creatine kinase levels in plasma of mice, was significantly reduced after toxin modification. In addition, liposome disruption activity was also significantly lower with the modified toxin both at 3 and 24 hr of incubation with the alkylating reagent. Some of the implications of these results on the structure-function relationship of myotoxins are discussed.

We also recommend Trading Suppliers and Manufacturers of 3-BROMOPHENACYL BROMIDE (cas 18523-22-3). Pls Click Website Link as below: cas 18523-22-3 suppliers

Prev:4-Bromophenacyl bromide induces Ca2+ influx in human gingival fibroblasts
Next:Synthesis and cytotoxic activity of novel 1-((indol-3-yl)methyl)–1H-imidazolium salts)